Journal Article Summary
The article investigates the long-term effects of stopping semaglutide treatment on weight maintenance in obese women with polycystic ovary syndrome (PCOS) who continued taking metformin. This topic is significant because many individuals experience weight regain after discontinuing anti-obesity medications like semaglutide, which can lead to health complications. Understanding how metformin might help maintain weight loss after stopping semaglutide could provide valuable insights for managing obesity in women with PCOS, a condition that often complicates weight management.
In this observational study, 25 women with PCOS and obesity participated, receiving semaglutide alongside metformin and lifestyle changes for 16 weeks. After semaglutide was stopped, participants continued with metformin for two years. The results showed that while participants regained about one-third of the weight lost during semaglutide treatment, they still maintained a significant net weight loss compared to their starting weight. Additionally, some improvements in metabolic health, such as cholesterol and glucose levels, reverted towards baseline after stopping semaglutide, although free testosterone levels remained stable.
The study has limitations, including a small sample size and the lack of a control group, which may affect the generalizability of the findings. Patients should be aware of these limitations and discuss their individual weight management strategies with healthcare professionals, especially considering the potential for weight regain after stopping medications like semaglutide. It is essential for patients to engage in shared decision-making with their healthcare providers regarding treatment options and lifestyle interventions to achieve sustainable weight management.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Jensterle Mojca, Ferjan Simona, Janez Andrej. The maintenance of long-term weight loss after semaglutide withdrawal in obese women with PCOS treated with metformin: a 2-year observational study. Frontiers in Endocrinology 2024. DOI: 10.3389/fendo.2024.1366940. PMID: 38665260. PMCID: PMC11043580.
Featured Pill Pals Product
Semaglutide with B-12 --- 10 mg / 2 mg / 4 ml --- 4 ml vial --- Weight Loss Glucagon-Like Peptide-1 (GLP-1)
Semaglutide with B-12 --- 10 mg / 2 mg / 4 ml --- 4 ml vial --- Weight Loss Glucagon-Like Peptide-1 (GLP-1) is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. Prescription required.
